[Aromatase inhibitors--new applications in gynecology].

Harefuah · 2004 · vol. 143(8) , pp. 580–4, 622 · PMID:15523811 · W2416193771
article OA: closed CC0
View on OpenAlex View on PubMed

Abstract

P-450 aromatase inhibitors, designed for suppressing estradiol production, were first approved for the treatment of advanced breast cancer. Recent studies have provided evidence that aromatase inhibitors may be effective in the short term for induction of ovulation and in the long-term for treatment of endometriosis. Based on current data, the role of aromatase inhibitors in the management of various gynecological conditions may soon be widely determined.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Aromatase Inhibitors Genital Diseases, Female Aromatase Inhibitors Endometriosis Endometriosis Estrogen Antagonists Estrogen Antagonists Female Genital Diseases, Female Humans Ovulation Induction

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:12:26.305326+00:00
License: CC0 · commercial use OK